C'RCLE Trademark

Trademark Overview


On Thursday, May 22, 2025, a trademark application was filed for C'RCLE with the United States Patent and Trademark Office. The USPTO has given the C'RCLE trademark a serial number of 99197885. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 28, 2026. This trademark is owned by Innovus Pharmaceuticals, Inc.. The C'RCLE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating allergies; Medicinal preparations for stimulating hair growth; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, and cognitive disorders; Smoking cessation preparations; Cough expectorants; Pharmaceutical preparations, namely, antivirals; Cold sore treatment preparations; Fever blister treatment preparations; Analgesics; Analgesic and anti-inflammatory preparations; Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases
c'rcle

General Information


Serial Number99197885
Word MarkC'RCLE
Filing DateThursday, May 22, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements


Description of MarkThe mark consistsĀ of the wording "C'RCLE" in stylized font, inside an outlined circle.
Pseudo MarkCIRCLE
Goods and ServicesPharmaceutical preparations for treating allergies; Medicinal preparations for stimulating hair growth; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, and cognitive disorders; Smoking cessation preparations; Cough expectorants; Pharmaceutical preparations, namely, antivirals; Cold sore treatment preparations; Fever blister treatment preparations; Analgesics; Analgesic and anti-inflammatory preparations; Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 22, 2025
Primary Code005
First Use Anywhere DateMonday, May 1, 2023
First Use In Commerce DateMonday, May 1, 2023

Trademark Owner History


Party NameInnovus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressReno, NV 89511
US

Trademark Events


Event DateEvent Description
Thursday, May 22, 2025NEW APPLICATION ENTERED
Thursday, May 22, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, October 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 22, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 23, 2025ASSIGNED TO EXAMINER
Tuesday, November 4, 2025NON-FINAL ACTION WRITTEN
Tuesday, November 4, 2025NON-FINAL ACTION E-MAILED
Tuesday, November 4, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 28, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 28, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 2, 2026NON-FINAL ACTION WRITTEN
Monday, March 2, 2026NON-FINAL ACTION E-MAILED
Monday, March 2, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 31, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, March 31, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 31, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, April 21, 2026APPROVED FOR PUB - PRINCIPAL REGISTER